Introduction: landscape of opioid dependence
- PMID: 20146548
- PMCID: PMC10437848
- DOI: 10.18553/jmcp.2010.16.s1-b.4
Introduction: landscape of opioid dependence
Abstract
Background: The use of opioids for chronic noncancer pain increased 222% from 1992 to 2002. Opioid dependence has also increased significantly, leading to a burden on patients, employers, insurers, society, and the entire health care system. It is imperative that opioid dependence is addressed and treated properly, in order to return patients to being productive participants in the workplace and society.
Objective: To provide an overview of addiction, abuse, and dependence and identify risk factors for addiction.
Summary: Studies have shown that intensive use of opioids is associated with increased utilization of costly health care services, prolonged disability, and continued use of opioids, leading to abuse and dependence in many patients. While identifying patients at risk for developing opioid dependence is difficult, there are many risk stratification tools now available to practitioners, including the Opioid Risk Tool (ORT) or Screener and Opioid Assessment for Patients with Pain (SOAPP). Understanding the differences between dependence, addiction, and tolerance is essential to managing patients on opioids.
Conclusion: It is imperative that patients be properly managed when being treated for pain. Physicians and employers have to be able to identify patients at risk for opioid abuse or exhibiting symptoms of opioid abuse and know how to address their needs.
Copyright 2010, Academy of Managed Care Pharmacy. All rights reserved.
Similar articles
-
Empirical view of opioid dependence.J Manag Care Pharm. 2010 Feb;16(1 Suppl B):S9-13. doi: 10.18553/jmcp.2010.16.s1-b.9. J Manag Care Pharm. 2010. PMID: 20146549 Free PMC article. Review.
-
Patient perspective, complexities, and challenges in managed care.J Manag Care Pharm. 2010 Feb;16(1 Suppl B):S22-5. doi: 10.18553/jmcp.2010.16.s1-b.22. J Manag Care Pharm. 2010. PMID: 20146551 Free PMC article. Review.
-
Chronic opioid therapy issues associated with opioid abuse potential.J Opioid Manag. 2009 Sep-Oct;5(5):287-300. doi: 10.5055/jom.2009.0029. J Opioid Manag. 2009. PMID: 19947070 Review.
-
Misuse of and dependence on opioids: study of chronic pain patients.Can Fam Physician. 2006 Sep;52(9):1081-7. Can Fam Physician. 2006. PMID: 17279218 Free PMC article. Review.
-
Opioid therapy in patients with chronic noncancer pain: diagnostic and clinical challenges.Adv Psychosom Med. 2011;30:61-91. doi: 10.1159/000324067. Epub 2011 Apr 19. Adv Psychosom Med. 2011. PMID: 21508626 Review.
Cited by
-
Astrocytic hypertrophy in the rat ventral tegmental area following chronic morphine differs with age.J Neurol Neurorehabilit Res. 2018;3(1):14-21. J Neurol Neurorehabilit Res. 2018. PMID: 29782623 Free PMC article.
-
Pharmacological Profiles of Oligomerized μ-Opioid Receptors.Cells. 2013 Oct 11;2(4):689-714. doi: 10.3390/cells2040689. Cells. 2013. PMID: 24709876 Free PMC article.
-
Elevated pain sensitivity in chronic pain patients at risk for opioid misuse.J Pain. 2011 Sep;12(9):953-63. doi: 10.1016/j.jpain.2011.02.357. Epub 2011 Jun 16. J Pain. 2011. PMID: 21680252 Free PMC article.
-
Effectiveness of a Retrospective Drug Utilization Review on Potentially Unsafe Opioid and Central Nervous System Combination Therapy.J Manag Care Spec Pharm. 2015 Oct;21(10):938-44. doi: 10.18553/jmcp.2015.21.10.938. J Manag Care Spec Pharm. 2015. PMID: 26402392 Free PMC article.
-
Improving public health through access to and utilization of medication assisted treatment.Int J Environ Res Public Health. 2011 Oct;8(10):4102-17. doi: 10.3390/ijerph8104102. Epub 2011 Oct 24. Int J Environ Res Public Health. 2011. PMID: 22073031 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical